Very impressed with the update, rather concerned at the moment that SBN simply do not have the resources to fend of competitors. They are like a very improvised man with gold in his pockets walking down a dark lane in NY. Fantastic product and obviously Dr Sun is their best asset. However with the USA market entrenched with urine testing and no FDA for not just Oraline but all salvia testing full stop, we have to wait for oversea JV to bring home the bacon. I think that is a year away, In the meantime Oraline is just sitting there ripe for the picking by any large hostile competitor. This is not a negative view more of a nervousness on how good a product SBN has.
- Forums
- ASX - By Stock
- SBN
- vulnerable
vulnerable
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)